Drugs / Influenza Vaccine, Live, Nasal, Freeze-dried
Influenza Vaccine, Live, Nasal, Freeze-dried
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06280144 | Sep 2023 → Jun 2024 | — | Changchun BCHT Biotechnology Co. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza Vaccine, Live, Nasal, Freeze-dried | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06280144 ↗ |
| Modality | Vaccine | “live attenuated influenza vaccine” NCT06280144 ↗ |
| Route | Intranasal | “freeze-dried nasal spray live attenuated influenza vaccine” NCT06280144 ↗ |